Sage Mountain Advisors LLC Raises Holdings in Johnson & Johnson $JNJ

Key Points

• Sage Mountain Advisors LLC increased its holdings in Johnson & Johnson by 12.5% in Q2, totaling 18,460 shares valued at approximately $2.82 million.
• Executive Vice President Jennifer L. Taubert sold 56,471 shares at an average price of $177.81, resulting in a significant decrease of 24.08% in her position.
• Johnson & Johnson is set to pay a quarterly dividend of $1.30 on December 9th, with an annualized yield of 2.7% and a payout ratio of 50.19%.

Sage Mountain Advisors LLC lifted its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 12.5% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 18,460 shares of the company's stock after acquiring an additional 2,052 shares during the period. Sage Mountain Advisors LLC's holdings in Johnson & Johnson were worth $2,820,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Johnson & Johnson by 0.5% in the first quarter. Vanguard Group Inc. now owns 233,962,679 shares of the company's stock valued at $38,800,371,000 after buying an additional 1,170,120 shares during the last quarter. Northern Trust Corp boosted its position in Johnson & Johnson by 0.4% in the first quarter. Northern Trust Corp now owns 30,943,820 shares of the company's stock valued at $5,131,723,000 after buying an additional 130,645 shares during the last quarter. Bank of New York Mellon Corp boosted its position in Johnson & Johnson by 26.4% in the first quarter. Bank of New York Mellon Corp now owns 23,182,464 shares of the company's stock valued at $3,844,580,000 after buying an additional 4,842,582 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Johnson & Johnson by 3.9% in the first quarter. Charles Schwab Investment Management Inc. now owns 18,899,263 shares of the company's stock valued at $3,133,602,000 after acquiring an additional 712,181 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its holdings in Johnson & Johnson by 2.5% in the first quarter. Massachusetts Financial Services Co. MA now owns 18,282,410 shares of the company's stock valued at $3,031,955,000 after acquiring an additional 448,666 shares during the period. Hedge funds and other institutional investors own 69.55% of the company's stock.

Insider Buying and Selling

In related news, EVP Jennifer L. Taubert sold 56,471 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $177.81, for a total value of $10,041,108.51. Following the completion of the transaction, the executive vice president directly owned 178,013 shares of the company's stock, valued at approximately $31,652,491.53. This represents a 24.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.16% of the company's stock.

Johnson & Johnson Trading Down 1.1%

Shares of JNJ stock opened at $190.38 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.07 and a quick ratio of 0.76. The company has a market cap of $458.69 billion, a price-to-earnings ratio of 18.38, a PEG ratio of 2.26 and a beta of 0.40. The stock has a 50 day simple moving average of $182.26 and a 200-day simple moving average of $166.13. Johnson & Johnson has a 1-year low of $140.68 and a 1-year high of $194.48.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last posted its quarterly earnings data on Wednesday, August 30th. The company reported $2.26 EPS for the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%.The firm had revenue of $24.02 billion during the quarter. On average, equities research analysts expect that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 25th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Tuesday, November 25th. Johnson & Johnson's dividend payout ratio is currently 50.19%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Citigroup boosted their price target on Johnson & Johnson from $213.00 to $215.00 and gave the company a "buy" rating in a report on Wednesday, October 15th. Morgan Stanley set a $190.00 price target on Johnson & Johnson in a report on Wednesday, October 15th. Piper Sandler reissued an "overweight" rating on shares of Johnson & Johnson in a report on Thursday, July 17th. Daiwa Capital Markets raised Johnson & Johnson from a "neutral" rating to an "outperform" rating and set a $203.00 price target for the company in a report on Monday, October 20th. Finally, HSBC boosted their price target on Johnson & Johnson from $210.00 to $215.00 and gave the company a "buy" rating in a report on Thursday, October 16th. Three investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, Johnson & Johnson has an average rating of "Moderate Buy" and a consensus price target of $199.05.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.